Skip to content

Eli Lilly LLY Change in AP

Change in AP at other companies

Pfizer logo
PfizerPFE
-$117.25M+54.2%
Amgen logo
AmgenAMGN
$571M+14.9%
Cardinal Health logo
Cardinal HealthCAH
$2.03B+120%
Mannkind logo
MannkindMNKD
$7.11M+506%
McKesson logo
McKessonMCK
$3.22B+101%
Exelixis logo
ExelixisEXEL
-$17.9M-311%

Other financials

Income statement

See full
Revenue$19.8B+55.5%
Gross profit$16.2B+54.4%
Net income$7.4B+168%
EPS (diluted)$8.26+170%

Balance sheet

See full
Cash & equivalents$5.3B+70.8%
Total debt$43.4B+12.6%
Total equity$31.2B+97.9%
Total assets$116.58B+30.4%

Cash flow

See full
Operating cash flow$5.3B+220%
CapEx$2.3B+54.0%
Free cash flow$3.0B+1,828%

Valuation

See full
Market cap$1.07T+49.8%
Enterprise value$1.11T+47.6%
P/E42.3×-9.4×
P/S14.8×+1.4×

Profitability

See full
Gross margin82.8%+1.1pp
Net margin35%+12.3pp
FCF margin16.4%+8.7pp

Returns & leverage

See full
Return on equity107.6%+29.9pp
Debt / equity1.4×-1.1×
Current ratio1.5×+0.1×

Where this comes from

Reported directly by Eli Lilly in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities.

The official record: Eli Lilly’s 10-K, filed February 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Eli Lilly's change in ap.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Eli Lilly's change in AP?
Eli Lilly (LLY) reported change in AP of $2.55B in Q4 2025.
How has Eli Lilly's change in AP changed year-over-year?
Eli Lilly's change in AP increased by 290.5% year-over-year, from $652.25M to $2.55B.
What is the long-term trend for Eli Lilly's change in AP?
Over 4 years (2021 to 2025), Eli Lilly's change in AP has grown at a 78.0% compound annual growth rate (CAGR), from -$1.01B to $10.19B.
What does change in AP mean?
Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.